Managing varicella zoster virus contact and infection in patients on anti-rheumatic therapy.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620384
Title:
Managing varicella zoster virus contact and infection in patients on anti-rheumatic therapy.
Authors:
Cates, Matthew; Donati, M.; Gillet, S.; Ustianowski, A.; Galloway, J.
Abstract:
Chickenpox and shingles can be more severe and occasionally life threatening in immunosuppressed patients. As such, some groups warrant a more detailed history, serological testing and consideration of prophylaxis following contact with the virus. Active disease may also require more aggressive treatment with antivirals. Guidance for the use of varicella zoster immunoglobulin has recently been updated by Public Health England with important implications for rheumatology patients.
Citation:
Managing varicella zoster virus contact and infection in patients on anti-rheumatic therapy. 2017 Rheumatology (Oxford)
Publisher:
Oxford Journals
Journal:
Rheumatology (Oxford, England)
Issue Date:
29-May-2017
URI:
http://hdl.handle.net/11287/620384
DOI:
10.1093/rheumatology/kex189
PubMed ID:
28575315
Additional Links:
https://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/kex189
Type:
Journal Article
Language:
en
ISSN:
1462-0332
Appears in Collections:
Rheumatology; 2017 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorCates, Matthewen
dc.contributor.authorDonati, M.en
dc.contributor.authorGillet, S.en
dc.contributor.authorUstianowski, A.en
dc.contributor.authorGalloway, J.en
dc.date.accessioned2017-09-08T08:58:43Z-
dc.date.available2017-09-08T08:58:43Z-
dc.date.issued2017-05-29-
dc.identifier.citationManaging varicella zoster virus contact and infection in patients on anti-rheumatic therapy. 2017 Rheumatology (Oxford)en
dc.identifier.issn1462-0332-
dc.identifier.pmid28575315-
dc.identifier.doi10.1093/rheumatology/kex189-
dc.identifier.urihttp://hdl.handle.net/11287/620384-
dc.description.abstractChickenpox and shingles can be more severe and occasionally life threatening in immunosuppressed patients. As such, some groups warrant a more detailed history, serological testing and consideration of prophylaxis following contact with the virus. Active disease may also require more aggressive treatment with antivirals. Guidance for the use of varicella zoster immunoglobulin has recently been updated by Public Health England with important implications for rheumatology patients.en
dc.language.isoenen
dc.publisherOxford Journalsen
dc.relation.urlhttps://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/kex189en
dc.rightsArchived with thanks to Rheumatology (Oxford, England)en
dc.subjectWessex Classification Subject Headings::Diseases & disorders of systemic, metabolic or environmental origin::Rheumatologyen
dc.titleManaging varicella zoster virus contact and infection in patients on anti-rheumatic therapy.en
dc.typeJournal Articleen
dc.identifier.journalRheumatology (Oxford, England)en
dc.type.versionIn press (epub ahead of print)en

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.